Hosted on MSN11mon
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's DataWAIS-IV is the most advanced adult measure of cognitive ability. Dalzanemdor (SAGE-718) was generally well-tolerated, and no new safety signals were observed. 48 participants experienced treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback